You are here

INVERSEON, INC.

Company Information
Address
INVERSEON, INC. 1701 JACKSON ST, #102
SAN FRANCISCO, CA 94109
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Novel Therapy for Asthma Targeting beta-Adrenoceptors

    Amount: $98,100.00

    DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease that effects approximately 17 million Americans. Despite the availability of inhaled beta-adrenoceptor (betaAR) agonists a ...

    STTRPhase I2004Department of Health and Human Services National Institutes of Health
  2. Combo beta-blockers & beta2-agonists for asthma therapy

    Amount: $98,100.00

    DESCRIPTION (provided by applicant): Approximately 5% of Americans have asthma, an inflammatory airway disease whose hallmark is airway hyper-reactivity (AHR). During AHR, bronchial smooth muscles rap ...

    STTRPhase I2004Department of Health and Human Services National Institutes of Health
  3. Combo beta-blockers & beta2-agonists for asthma therapy

    Amount: $98,100.00

    DESCRIPTION (provided by applicant): Approximately 5% of Americans have asthma, an inflammatory airway disease whose hallmark is airway hyper-reactivity (AHR). During AHR, bronchial smooth muscles rap ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  4. Novel Therapy for Asthma Targeting beta-Adrenoceptors

    Amount: $98,100.00

    DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease that effects approximately 17 million Americans. Despite the availability of inhaled beta-adrenoceptor (betaAR) agonists a ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government